Surgery Partners, Inc. (SGRY)

Surgery Partners Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	98.9	12.5	135.3	87	70.7
Depreciation & Amortization	176	152.6	118.1	114.8	98.8
Stock-Based Compensation	14.8	33.3	17.7	18.4	17.4
Other Adjustments	95	220.6	86.2	99.3	81.5
Change in Receivables	-53.8	-72.1	-47.2	-35.3	-32.1
Changes in Other Operating Activities	-56.6	-46.8	-16.3	-125.4	-149.2
Operating Cash Flow	274.3	300.1	293.8	158.8	87.1
Operating Cash Flow Growth	-8.60%	2.14%	85.01%	82.32%	-64.72%
Capital Expenditures	-78.7	-90.4	-88.8	-80.6	-57.6
Sale of Property, Plant & Equipment	46.5	2.6	25.8	12.9	6
Purchases of Investments	-13.3	-1.7	-50.3	-95.1	-
Proceeds from Sale of Investments	1.5	4.6	1.4	12.8	5.4
Payments for Business Acquisitions	-162.1	-378.8	-80	-146.4	-285.8
Other Investing Activities	-40.5	-24.8	-33.7	-11.5	0.3
Investing Cash Flow	-246.6	-488.5	-225.6	-307.9	-331.7
Long-Term Debt Issued	1,203	1,730	826.6	217.8	299.4
Long-Term Debt Repaid	-1,040	-1,279	-807.1	-873.3	-343.2
Net Long-Term Debt Issued (Repaid)	162.8	450.4	19.5	-655.5	-43.8
Issuance of Common Stock	-	-	-	857.7	554.2
Net Common Stock Issued (Repurchased)	-	-	-	857.7	554.2
Preferred Share Dividends Paid	-	-	-	-	-5.1
Other Financing Activities	-220.1	-188.4	-174.7	-160.1	-189
Financing Cash Flow	-57.3	262	-155.2	42.1	316.3
Net Cash Flow	-29.6	73.6	-87	-107	71.7
Free Cash Flow	195.6	209.7	205	78.2	29.5
Free Cash Flow Growth	-6.72%	2.29%	162.15%	165.08%	-85.54%
FCF Margin	-	-	-	3.08%	1.33%
Free Cash Flow Per Share	1.54	1.66	1.63	0.85	0.41
Levered Free Cash Flow	125.6	297.7	20.6	-801.3	-303.9
Unlevered Free Cash Flow	490.17	683.36	340.27	326.92	233.28

Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q